- Home
- ACIU vs PDLB Comparison
ACIU vs PDLB Comparison
Compare ACIU & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PDLB
- Stock Information
- Founded
- ACIU 2003
- PDLB 1960
- Country
- ACIU Switzerland
- PDLB United States
- Employees
- ACIU N/A
- PDLB N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PDLB
- Sector
- ACIU Health Care
- PDLB
- Exchange
- ACIU Nasdaq
- PDLB Nasdaq
- Market Cap
- ACIU 332.4M
- PDLB 291.6M
- IPO Year
- ACIU 2016
- PDLB 2017
- Fundamental
- Price
- ACIU $3.15
- PDLB $12.98
- Analyst Decision
- ACIU Strong Buy
- PDLB
- Analyst Count
- ACIU 2
- PDLB 0
- Target Price
- ACIU $12.00
- PDLB N/A
- AVG Volume (30 Days)
- ACIU 153.3K
- PDLB 40.9K
- Earning Date
- ACIU 11-05-2024
- PDLB 01-28-2025
- Dividend Yield
- ACIU N/A
- PDLB N/A
- EPS Growth
- ACIU N/A
- PDLB N/A
- EPS
- ACIU N/A
- PDLB 0.37
- Revenue
- ACIU $48,505,404.00
- PDLB $79,488,000.00
- Revenue This Year
- ACIU $85.33
- PDLB N/A
- Revenue Next Year
- ACIU $80.69
- PDLB $11.39
- P/E Ratio
- ACIU N/A
- PDLB $35.39
- Revenue Growth
- ACIU 4097200.00
- PDLB 33.32
- 52 Week Low
- ACIU $2.25
- PDLB $7.89
- 52 Week High
- ACIU $5.14
- PDLB $13.24
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- PDLB 60.14
- Support Level
- ACIU $3.10
- PDLB $12.57
- Resistance Level
- ACIU $3.25
- PDLB $13.24
- Average True Range (ATR)
- ACIU 0.14
- PDLB 0.23
- MACD
- ACIU -0.02
- PDLB -0.01
- Stochastic Oscillator
- ACIU 13.16
- PDLB 63.89
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.